HealthPhoto: Hindu WorldEbola Vaccine Trial Starts in DR Congo Amid Outbreak
The first clinical trial of an Ebola vaccine began on October 23, 2026, in the Democratic Republic of Congo (DRC), aiming to test the Ervebo vaccine's effectiveness against the Bundibugyo strain. Ervebo is already approved for the Zaire strain. This trial comes amid the DRC's worst Ebola outbreak, which has caused over 4,000 deaths. Health workers are administering the Tumaini vaccine in Ituri, Congo.
Hindu World··Ituri


